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Background. Cannabis use is considered a component cause of psychotic illness, interacting with genetic and other
environmental risk factors. Little is known, however, about these putative interactions. The present study
investigated whether an urban environment plays a role in moderating the eﬀects of adolescent cannabis use on
psychosis risk.
Method. Prospective data (n=1923, aged 14–24 years at baseline) from the longitudinal population-based German
Early Developmental Stages of Psychopathology cohort study were analysed. Urbanicity was assessed at baseline
and deﬁned as living in the city of Munich (1562 persons per km2 ; 4061 individuals per square mile) or in the rural
surroundings (213 persons per km2 ; 553 individuals per square mile). Cannabis use and psychotic symptoms were
assessed three times over a 10-year follow-up period using the Munich version of the Composite International
Diagnostic Interview.
Results. Analyses revealed a signiﬁcant interaction between cannabis and urbanicity [10.9% adjusted diﬀerence in
risk, 95% conﬁdence interval (CI) 3.2–18.6, p=0.005]. The eﬀect of cannabis use on follow-up incident psychotic
symptoms was much stronger in individuals who grew up in an urban environment (adjusted risk diﬀerence 6.8%,
95% CI 1.0–12.5, p=0.021) compared with individuals from rural surroundings (adjusted risk diﬀerencex4.1%, 95%
CIx9.8 to 1.6, p=0.159). The statistical interaction was compatible with substantial underlying biological synergism.
Conclusions. Exposure to environmental inﬂuences associated with urban upbringing may increase vulnerability to
the psychotomimetic eﬀects of cannabis use later in life.
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Introduction
Adolescent cannabis use may increase the risk of
psychotic disorder (Henquet et al. 2005b ; Semple et al.
2005 ; Moore et al. 2007), the ﬁrst stage of which is
expressed as abnormal persistence of subclinical psy-
chotic symptoms (Cougnard et al. 2007 ; Kuepper et al.
2011). However, only a minority of cannabis users will
eventually develop a psychotic disorder and many
individuals with psychotic illness have never been
exposed to cannabis. Therefore, cannabis use probably
constitutes a component cause, co-depending on
other causal inﬂuences in shaping risk for psychosis
(Henquet et al. 2008). Little is known, however, about
the nature of these putative interactions (Caspi et al.
2005 ; Henquet et al. 2005a ; van Os et al. 2010).
Using data from the prospective German Early
Developmental Stages of Psychopathology (EDSP)
study (Wittchen et al. 1998b ; Lieb et al. 2000), Henquet
et al. (2005b) showed that individuals scoring high on
schizotypy had a much higher risk of developing psy-
chotic symptoms after cannabis use compared with
individuals with low or average schizotypy scores
(Henquet et al. 2005a). A subsequent study suggested
that the moderating eﬀect of schizotypy on the
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psychotomimetic eﬀect of cannabis use may be medi-
ated by genetic risk for psychotic disorder [Genetic
Risk and Outcome in Psychosis (GROUP) Investi-
gators, 2011], with some evidence for speciﬁc molecu-
lar genetic variation (Caspi et al. 2005 ; Henquet et al.
2006 ; van Winkel, 2011). Environmental factors may
similarly moderate the long-term eﬀects of cannabis
on psychosis outcomes, as both Houston et al. (2008)
and Harley et al. (2009) reported that individuals who
were exposed to trauma early in life, compared with
those without trauma, had a much higher risk to de-
velop psychotic outcomes following adolescent can-
nabis use. Thus, the risk conveyed by the combination
of cannabis and trauma was much higher than the
sum of the risk posed by either factor alone (Houston
et al. 2008 ; Harley et al. 2009).
Other environmental risk factors may also interact
with cannabis use. For example, there is evidence that
cannabis use, childhood trauma and growing up in
an urban environment independently increase the
risk of onset and persistence of psychotic symptoms
(Cougnard et al. 2007). It has been hypothesized that
all three risk factors may be associated with the same
underlying mechanism of behavioural ‘sensitization’
over time (Collip et al. 2008 ; van Winkel et al. 2008 ;
Lardinois et al. 2011). Meta-analyses suggest that
growing up in an urban environment is consistently
associated, in a dose–response fashion, with increased
psychosis risk (Krabbendam & van Os, 2005 ; March
et al. 2008 ; Kelly et al. 2010), particularly if there is
additional evidence of genetic risk (van Os et al. 2003,
2004 ; Weiser et al. 2007). The aim of the present study
was to investigate whether environmental factors as-
sociated with urbanicity moderate the strength of the
cannabis–psychosis relationship. Data from the EDSP
study (Wittchen et al. 1998b ; Lieb et al. 2000) were
analysed to investigate interaction between cannabis
use and urbanicity on later expression of psychotic
symptoms in adolescents and young adults.
Method
Sample and study design
The EDSP study collected data on the prevalence,
incidence, risk factors, co-morbidity and course of
mental disorders in a random, representative popu-
lation sample of adolescents and young adults in the
general population (Wittchen et al. 1998b ; Lieb et al.
2000). The baseline sample, following ethics com-
mittee approval, was randomly drawn, in 1994, from
the respective population registry oﬃces of Munich
and its 29 counties, to mirror the distribution of indi-
viduals expected to be 14–24 years of age at the time
of the baseline (T0) interview in 1995. The members of
the base population were all those born between
1 June 1970 and 31 May 1981, registered as residents in
these localities and having German citizenship. These
registers can be regarded as highly accurate because:
(1) each German is registered by his town; (2) they
are regularly updated; (3) in the interest of scientiﬁc
studies, any number of randomly drawn addresses
with a given sex and age group can be obtained; (4)
and strict enforcement of registration by law and
the police applies. More details on the sampling, rep-
resentativeness, instruments, procedures and statisti-
cal methods of the EDSP study sample have been
presented previously (Wittchen et al. 1998b ; Lieb et al.
2000).
The overall design of the cohort study is longitudi-
nal and prospective, consisting of a baseline survey
(T0) and three follow-up surveys (T1, T2 and T3),
covering time periods on average for T0–T1 of 1.6
(S.D.=0.2) years, for T0–T2 of 3.5 (S.D.=0.3) years and
for T0–T3 of 8.4 (range=7.3–10.5, S.D.=0.7) years.
Because the primary goal of the study was to examine
the incidence and developmental risk factors for
psychopathology, the younger group (14–15 years),
presumed to have the highest incidence density, was
sampled at twice the rate of persons aged 16–21 years,
and the oldest group (22–24 years) was sampled at
half this rate. For the same reason, subjects aged
14–17 years at baseline were examined at the four time
points and subjects aged 18–24 years were assessed
only three times (T0, T2, T3). The present study is
based on the whole cohort assessed at T0, T2 and T3.
Response rates were 84% (n=2548) for T2 and 74%
(n=2210) for T3.
Instruments
Participants were assessed using the computerized
version of the Munich-Composite International
Diagnostic Interview (DIA-X/M-CIDI) (Wittchen et al.
1998a), an updated version of the World Health
Organization’s Composite International Diagnostic
Interview (CIDI) version 1.2 (Robins et al. 1988). The
DIA-X/M-CIDI is a comprehensive, fully standar-
dized diagnostic interview and assesses symptoms,
syndromes and diagnoses of various mental disorders
in accordance with the deﬁnitions and criteria of
the International Classiﬁcation of Diseases, Tenth
Revision (ICD-10), and the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-
IV), along with information about onset, duration,
severity of symptoms and psychosocial impairment.
The CIDI has been primarily designed for use in epi-
demiological studies of mental disorders and can also
be used for clinical purposes. It is divided into 16 sec-
tions : one sociodemographic section, 12 sections
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assessing 288 symptoms of groups of mental disorders
(including ‘somatoform and dissociative ’, ‘phobic
and other anxiety’, ‘depressive and dysthymic ’,
‘manic and bipolar aﬀective ’, ‘ schizophrenia and
other psychotic ’, ‘eating’, ‘dementia and other cog-
nitive ’, ‘post-traumatic stress ’ as well as ‘ tobacco’,
‘alcohol ’ and ‘substance-related’ disorders) and three
ﬁnal sections containing concluding questions, inter-
viewer observations and interviewer ratings. The
instrument, designed for use by trained interviewers
who are not clinicians, has shown high inter-rater
(Cottler et al. 1991 ; Wittchen et al. 1991) and test–retest
reliability (Wittchen, 1994 ;Wittchen et al. 1998a). How-
ever, the assessment of psychosis with CIDI by lay
interviewers is not considered reliable. Therefore, in
the EDSP study, trained and experienced clinical inter-
viewers at the level of clinical psychologist, who were
allowed to probe with follow-up clinical questions,
conducted the interviews in the respondents’ homes.
At baseline, the DIA-X/M-CIDI lifetime version was
used. At each of the follow-up assessments, partici-
pants applied the interval version, which covers the
period of assessment from the last interview until the
next. Data on the G-section concerning psychosis and
its clinical relevance were collected at T2 (lifetime
version) and T3 (interval version).
Assessment of psychotic experiences
Data on positive psychotic experiences were collected
at time T2 (lifetime version) and T3 (interval version)
using the G-section of the DIA-X/M-CIDI. Presence
of positive psychotic experiences was broadly deﬁned
as any rating of ‘present ’ on any of the 20 DIA-X/
M-CIDI core psychosis items (G1, G2a, G3–G5,
G7–G13, G13b, G14, G17, G18, G20, G20C, G21 and
G22a), including 14 delusion items, ﬁve hallucination
items and one item on passivity phenomena. Items
relating to classic psychotic symptoms involve, for
example, persecution, thought interference, auditory
hallucinations and passivity phenomena. Participants
were ﬁrst invited by the psychologist to read a list of
all the psychotic experiences and then asked whether
they ever experienced such symptoms. All these psy-
chosis items were rated in two ways: ‘absent ’ and
‘present ’. Thus, all the psychosis DIA-X/M-CIDI
items used in the present study were coded in a di-
chotomous manner without intermediate levels.
Assessment of urbanicity
Urbanicity was assessed at baseline (T0) and was
deﬁned dichotomously as either living in the city of
Munich (1562 persons per km2 ; 4061 persons per
square mile) or in the rural surroundings (213 persons
per km2 ; 553 persons per square mile) at the time of
inclusion. Data on living location were derived from
the population registry oﬃces of the city and the
29 counties of Munich.
Assessment of cannabis use
Cannabis use was assessed with the L-section of the
DIA-X/M-CIDI at all three assessments. Conforming
with previous analyses (Henquet et al. 2005a), canna-
bis use at T0 was deﬁned as lifetime use of cannabis of
ﬁve times or more (‘T0 cannabis use ’) and cannabis
use at T2 was deﬁned as use of cannabis of ﬁve times
or more since T0 (‘T2 cannabis use’).
Statistical analyses
Data were analysed using Stata, release 10.0
(StataCorp LP, USA). Associations are expressed as
risk diﬀerences (RDs) from logistic regression models.
Cannabisrurbanicity interaction
To investigate whether the eﬀects of incident cannabis
use over the T0–T2 period on expression of incident
psychotic experiences over the T2–T3 period were
moderated by the urban environment, the interaction
between T0–T2 cannabis use and urbanicity was cal-
culated under an additive model (van Os et al. 2003,
2004). This was done as the additive interaction can be
interpreted in a meaningful way, yielding information
on the extent to which two causes biologically depend
on each other or co-participate in disease causation
(Darroch, 1997). Thus, we derived from the additive
statistical interaction an estimate of the amount of bio-
logical synergism, as originally described by Darroch
(1997), and since successfully applied to psychiatric
research (Corcoran & Malaspina, 2001 ; van Os et al.
2002 ; Clarke et al. 2009). The amount of biological
synergism in this context can be understood as the
proportion of individuals exposed to both cannabis
use and urbanicity that developed the psychosis out-
come because of the speciﬁc co-participation of these
two factors. If this proportion is low, the statistical
interaction is of little practical importance as most in-
dividuals exposed to both cannabis use and urbanicity
will have developed the outcome because of either
cannabis or urbanicity in isolation, not because of their
synergistic action (Darroch, 1997). How the amount of
biological synergism can be estimated approximately
from the additive statistical interaction has been de-
scribed in detail previously (Darroch, 1997 ; van Os
et al. 2002).
To ensure prediction of strictly incident psychotic
symptoms over the T2–T3 follow-up period, all indi-
viduals who had reported lifetime psychotic experi-
ences at T2 were excluded from the analyses. The
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interaction between T0–T2 cannabis use and urbani-
city was calculated using the BINREG procedure in Stata
yielding RDs, followed by calculation of the appro-
priate linear combinations from the model with the
interaction, using the Stata LINCOM command.
In addition, in order to check for possible mediation
between cannabis and urbanicity (in the sense of one
factor inﬂuencing the occurrence of the other), logistic
regression analysis was used to test whether urbani-
city was associated with T0 cannabis use.
All analyses were a priori adjusted for the follow-
ing confounding risk factors : age (in years) ; sex
(0=female, 1=male) ; socio-economic status (lower,
middle, upper, other) ; cannabis use at baseline (to
control for possible mediating eﬀects between urbani-
city and cannabis use) ; use of other drugs ; and child-
hood trauma (Read et al. 2005). Use of ‘other drugs’
included psychostimulants, sedatives, opiates, co-
caine, phencyclidine and psychedelic drugs and refers
to use of ﬁve times or more of any of these drugs, as
assessed with the L-section of the M-CIDI. Conform-
ing to previous analyses in this sample (Spauwen et al.
2006), ‘childhood trauma’ was deﬁned as lifetime
experience of any traumatic experience during child-
hood as assessed with the N-section of the M-CIDI,
dichotomously deﬁned as ‘present ’ versus ‘absent ’.
Results
Sample
A total of 2210 individuals completed the T3 assess-
ment (response rate 74.0%) Of them, 287 participants
had partial missing information on substance use and
psychotic symptoms, resulting in a ﬁnal risk set for
analysis of 1923 individuals of which 926 (48.2%) were
men (Fig. 1). Mean age was 18.3 (S.D.=3.3) years at T0,
21.8 (S.D.=3.4) years at T2 and 26.6 (S.D.=3.5) years at
T3. Participant characteristics of the risk set are sum-
marized in Table 1.
At T0, 247 participants (12.8%) reported lifetime
cannabis use. At T2, 392 participants (20.4%) reported
using cannabis over the T0–T2 interval and 381 in-
dividuals (27.1%) reported T2–T3 interval cannabis
use at T3. Psychotic symptoms were reported by
436 participants (22.7% – lifetime) at T2 and by 231
participants (12.0% – interval) at T3. At the time of
inclusion, 1345 (69.9%) participants were registered
as living in the city of Munich; 578 participants
(30.1%) were registered as living in the rural sur-
roundings.
Baseline sample
n = 3021
T2 (3.5-year follow-up):
n = 2548 (response rate 84%)
T3 (8.4-year follow-up):
n = 2210 (response rate 73%)
Partial missing information in 287
individuals
Risk set n = 1923 
Loss to follow-up: 473 individuals
Main reasons: refusal to participate, failure 
to contact the individual, lack of time 
Loss to follow-up: 338 individuals
Main reasons: refusal to participate, failure 
to contact the individual, lack of time 
Fig. 1. Schematic illustration of attrition at each stage of the
study.
Table 1. Participant characteristics of the risk set (n=1923)
n %
Sex
Male 926 48.2
Female 997 51.8
Socio-economic statusa
Lower 115 6.0
Middle 1114 58.0
Upper 661 34.4
Other 33 1.7
Urbanicityb
Urban 1345 69.9
Rural 578 30.1
Childhood traumac
Yes 363 18.9
No 1560 81.1
Cannabis use at T0d
Yes 247 12.8
No 1676 87.2
Use of other drugs at T0d
Yes 36 1.9
No 1887 89.1
T0, Baseline.
a Socio-economic status : lower (lower class, lower middle
class) ; middle (middle middle class) ; upper (higher middle
class, upper class) ; other (none of the above or missing).
b Urbanicity : urban (the city of Munich : 1562 persons per
km2 ; 4061 persons per square mile) ; rural (the surroundings
of Munich : 213 persons per km2 ; 553 persons per square
mile).
c Childhood trauma : any traumatic experience during
childhood.
d Cannabis use and use of other drugs : any use of more
than ﬁve times.
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Main eﬀects of cannabis and urbanicity
In individuals with no history of psychotic symptoms,
cannabis use over the T0–T2 period was signiﬁcantly
associated with incident psychotic symptoms over the
T2–T3 period [unadjusted odds ratio (OR)=1.77, 95%
conﬁdence interval (CI) 1.16–2.70, p=0.008]. After ad-
justment for age, sex, socio-economic status, cannabis
use at baseline, childhood trauma and use of other
drugs, the strength of the association was reduced
somewhat (adjusted OR=1.59, 95% CI 0.98–2.60,
p=0.061). There was no signiﬁcant association be-
tween urbanicity and incident psychotic symptoms
over the T2–T3 period (adjusted OR=1.16, 95% CI
0.77–1.76, p=0.497).
Interaction between cannabis and urbanicity
Analysis revealed a signiﬁcant interaction between
T0–T2 cannabis use and urbanicity (test for additive
interaction : 10.9% adjusted diﬀerence in risk, 95% CI
3.2–18.6, p=0.005; Table 2). The association between
T0–T2 cannabis use and T2–T3 psychosis was much
stronger for individuals from an urban environment
(adjusted RD 6.8%, 95% CI 1.0–12.5, p=0.021 ; Table 2)
compared with individuals from rural surroundings
(adjusted RD x4.1%, 95% CI x9.8 to 1.6, p=0.159;
Table 2).
Further analyses revealed that biological synergism
was between 51% and 66%, i.e. of all the individuals
in the risk set exposed to both urbanicity and cannabis,
the majority had developed the psychosis outcome
because of the speciﬁc synergistic eﬀect of the two,
assuming causality.
There was a small but signiﬁcant positive associ-
ation between urbanicity and T0 cannabis use (ad-
justed OR=1.4, 95% CI 1.02–1.98, p=0.038).
Discussion
There was evidence that urbanicity may moderate the
long-term eﬀects of cannabis on psychosis : ado-
lescents who grew up in the city of Munich were much
more likely to develop psychotic symptoms after can-
nabis use than individuals who grew up in the rural
surroundings of Munich. This interaction eﬀect was
independent of confounding factors such as age, sex,
socio-economic status, use of other drugs and child-
hood trauma and was not irrelevant, as the majority of
those exposed to both urbanicity and cannabis devel-
oped the psychosis outcome because of their co-action.
There was also some evidence that this interaction
could be interpreted in the sense of mediation (urbani-
city leading to cannabis use leading to psychosis), as
a small but signiﬁcant association existed between
urbanicity and cannabis use.
Cannabis and urbanicity : moderation and possible
mechanisms
The present study identiﬁed urbanicity as one of the
factors that may moderate the association between
cannabis and psychosis. Previously, a similar inter-
action was reported between cannabis and develop-
mental trauma, another environmental exposure
associated with psychotic outcomes (Houston et al.
2008 ; Harley et al. 2009). Given evidence that cannabis,
trauma and urbanicity do not reﬂect the same
Table 2. Interaction between cannabis use and urbanicitya
T2 cannabis
use
Number with
psychotic
symptomsb
Number
without
psychotic
symptomsb
Psychotic
symptoms, %
Unadjusted
RD, %
Adjustedc RD
(95% CI), % p
Test for overall
interactiond
Adjusted RD
(95% CI), % p
Rural
10.9 (3.2–18.6) 0.005
No 30 355 7.8
x2.1
x4.1 (–9.8 to 1.6) 0.159
Yes 4 66 5.7
Urban
No 60 774 7.2
7.6
6.8 (1.0 to 12.5) 0.021
Yes 29 167 14.8
T2, Second follow-up ; RD, risk diﬀerence ; CI, conﬁdence interval ; T3, third follow-up ; DIA-X/M-CIDI, Munich-Composite
International Diagnostic Interview.
a Individuals with T2 lifetime psychotic experiences were excluded from the analyses.
b Assessed at T3 as follows : any rating of ‘present ’ on any of the 20 DIA-X/M-CIDI core psychosis items.
c Adjusted for age, sex, socio-economic status, baseline cannabis use, use of other drugs and childhood trauma.
d Tests whether cannabis RD in exposure group (‘urban ’) is signiﬁcantly greater than RD in non-exposure group (‘ rural ’).
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environmental inﬂuence in the association with psy-
chotic outcomes (Cougnard et al. 2007), the current
analyses, in combination with the ﬁndings on similar
moderation by developmental trauma (Houston et al.
2008 ; Harley et al. 2009), suggest that they do share
the same interactive pathway. A mechanism of devel-
opmental sensitization has been suggested to underlie
this pathway (Collip et al. 2008).
Epidemiological evidence indicates that although
developmental expression of subclinical psychotic ex-
periences in adolescence is mostly transient, repeated
exposure to environmental risk factors causes sub-
clinical psychotic experiences to persist and become
more severe, resulting in onset of psychotic illness
in a minority of individuals (Cougnard et al. 2007 ;
Dominguez et al. 2011 ; Mackie et al. 2011). Urbanicity
represents a complex proxy environmental inﬂuence,
and the mechanism of its impact on psychosis remains
largely unknown. The eﬀect does not appear to be
mediated by demographic factors, obstetric complica-
tions, childhood socio-economic position, neuro-
psychological impairment, air pollution, drug use or
ethnic group. However, there is evidence that ex-
posure between the ages of 5 and 15 years is associated
with the greatest eﬀect (Krabbendam & van Os, 2005 ;
March et al. 2008 ; Kelly et al. 2010), suggesting
mediation by factors that have an impact during de-
velopment. One study showed that an urban environ-
ment induced anxiety, negative feelings towards other
people and reasoning biases associated with delu-
sional ideation (Ellett et al. 2008). Allardyce et al. (2005)
showed that social fragmentation as well as depri-
vation had a signiﬁcant eﬀect on ﬁrst psychosis ad-
mission rates independently of urbanicity, and that
the eﬀect of urbanicity on ﬁrst psychosis admission
rates disappeared after statistical adjustment for social
fragmentation and deprivation (Allardyce et al. 2005).
Similarly, there is evidence that risk for psychotic
syndrome associated with indicators of social mal-
adjustment, for example single parent family, single
marital status and residential instability, similarly
varies with the degree to which this represents the
exception in relation to the wider social environment
(van Os et al. 2000; Zammit et al. 2010). This type of
interaction between individual-level and area-level
social ‘ fragmentation’ may mediate the eﬀect of the
urban environment (Zammit et al. 2010).
The absence of an association between urban
environment and incident psychotic symptoms in the
current study is in line with previous research (Wiles
et al. 2006). The likely explanation is that the time
window of exposure to an urban environment in re-
lation to risk for psychosis outcomes is from 5 to
15 years (Pedersen & Mortensen, 2001). Individuals
with lifetime psychotic symptoms, assessed at
baseline, that previous work in this sample showed
were associated with urban environment (Spauwen
et al. 2004), were excluded from the analyses. Later-
onset ‘ incident ’ psychotic symptoms could not be
traced directly anymore to earlier exposure to the ur-
ban environment, although an indirect eﬀect was still
apparent, through moderation of sensitivity to the
psychotomimetic eﬀects of cannabis. It may be hy-
pothesized that early exposure, i.e. between the ages
of 5 and 15 years, to increased social fragmentation
associated with an urban environment may constitute
an environmental stressor that, through epigenetic
mechanisms, leads to permanent neurodevelopmental
alterations, which in turn may contribute to enhanced
sensitivity to the psychotomimetic eﬀects of cannabis
later in life.
Cannabis and urbanicity : moderation or mediation?
In the present study, a small but signiﬁcant association
was found between urbanicity and cannabis use : in-
dividuals living in the urban environment were more
likely to use cannabis at baseline than individuals
from the rural area. This ﬁnding indicates that the
interaction between cannabis use and urbanicity may
represent not only an underlying mechanism of mod-
eration (the psychotomimetic eﬀect of cannabis is
larger in urban areas) but also of mediation (living in
the city may enhance cannabis use). Both mechanisms
would be important from a public health perspective.
Cannabis · urbanicity : what it does and what it
does not tell us?
One of the limitations of epidemiological research
concerns the inability to make inferences about under-
lying molecular mechanisms. Therefore, our ﬁndings
are not informative with regard to molecular mech-
anisms such as developmental sensitization. However,
when epidemiological research is followed by targeted
experimental animal and human research, it may
constitute the ﬁrst step in a chain of research eﬀorts to
uncover the biological mechanisms of environment–
environment or gene–environment interaction (van Os
et al. 2010). Thus, the fact that the majority of those
exposed to both cannabis and urbanicity developed
the psychosis outcome because of a speciﬁc mechan-
ism of co-participation between these two factors
suggests that the ﬁnding constitutes an important
starting point requiring follow-up experimental re-
search targeting a ﬁnal common pathway that both
factors may make an impact on.
The interest of epidemiological ﬁndings like these
lies in the area of public health and disease causation.
As shown by Darroch (1997), evidence of non-
additivity represents a way to estimate the population
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amounts of biological synergism (the population ex-
posed to both risk factors that developed the outcome
because of the speciﬁc co-participation between the
two factors) and biological parallelism (the population
exposed to both risk factors that developed the
outcome because of the action of only one factor).
Examination of biological synergism and parallelism
is of vital interest to epidemiologists and public health,
since it allows identiﬁcation of populations that would
beneﬁt most from a given intervention : if synergism
is large, public health gains could be obtained by tar-
geting either factor. On the other hand, if parallelism is
large, public health may gain by targeting both factors.
In the current study, synergism was between 50%
and 65%, indicating that targeting either factor could
potentially result in public health gains.
Limitations and methodological issues
There are several limitations. First, information on
substance use and psychosis outcome was acquired
using the M-CIDI, which is meant to essentially
provide self-reported information. Nevertheless, the
interview was conducted face-to-face by clinical psy-
chologists who were allowed to follow up with clinical
questioning in order to ensure systematic and valid
assessment of outcomes. This method can therefore be
assumed to yield better and more valid results than a
self-report questionnaire.
Second, urbanicity was assessed by retrieving data
on living location from the German registry oﬃces.
Although these registers can be considered as highly
accurate since in Germany registration is obligatory
and registries are regularly updated, the information
is restricted to current living location and therefore
does not provide information on duration of living at a
certain location. Pedersen & Mortensen (2001) showed
that increasing duration of living in urban areas leads
to increased psychosis risk in a dose–response fashion.
Research has furthermore suggested that the eﬀect
of urbanicity on psychosis risk operates during up-
bringing rather than at birth (Pedersen & Mortensen,
2001) or around illness onset (Marcelis et al. 1999).
Considering the current study, even under the hypo-
thetical assumption that participants registered as
living in the city of Munich had just moved there from
the rural surroundings or, the other way round, in-
dividuals from the rural surroundings had just moved
to the city, this would have yielded an underesti-
mation, rather than an overestimation of the eﬀect size.
In addition, previous work suggests that current
urban residence in young people reﬂects urban up-
bringing in the majority (Marcelis et al. 1999).
The paradigm used in the current study was
based on the notion that psychotic symptoms can be
expressed below the threshold of diagnosis and are
meaningful in relation to the clinical phenotype. Meta-
analytic work of subdiagnostic expression of psychotic
experiences in the general population has shown
aetiological, psychopathological and longitudinal
continuity between the extended subclinical pheno-
type and clinical expression of psychotic disorder, as
well as a similar age-related developmental pattern
of expression (van Os et al. 2009) ; a recent landmark
general population birth cohort study conﬁrmed this
pattern of ﬁndings (Polanczyk et al. 2009). Further,
since transient and normally expressed psychotic ex-
periences may, under certain circumstances, become
abnormally persistent and develop into clinical psy-
chosis (Hanssen et al. 2005 ; Cougnard et al. 2007 ;
Dominguez et al. 2011), psychotic experiences rep-
resent an important phenotype for the investigation of
mechanisms and pathways by which environmental
risk factors such as cannabis make an impact on psy-
chosis risk (Kuepper et al. 2011).
Finally, in interpreting the ﬁndings of this current
study, it was assumed that in this area in Germany,
cannabis used in the city does not diﬀer from cannabis
used in rural areas. Although this cannot be formally
explored the assumption may be valid, since avail-
ability of cannabis in Germany is limited in general
(compared with countries such as the Netherlands,
where ‘coﬀee shops’ are allowed to sell cannabis on a
semi-legal basis) and access to cannabis is probably
comparable between rural and urban areas.
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